Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Ann Surg Oncol. 2017 Jul 17;24(11):3180–3187. doi: 10.1245/s10434-017-6007-z

Table 4.

Intraoperative variables by ERAS protocol vs PVB block alone.

Intraoperative Effects of ERAS
ERAS (n=19) No ERAS (n=47) P
Intraoperative Variables
Mean SD Mean SD P
Intraop Heart Rate 81.2  ±  7.3 81.5  ±  9.4 0.87
Intraop MAP (mmHg) 67.4  ±  3.3 69.7  ±  7.9 0.23
Intraop SBP (mmHg) 105.7  ±  5.4 105.4  ±  10.6 0.89
Intraop DBP (mmHg) 56.4  ±  3.8 58.2  ±  7.8 0.28
Time MAP < 65mmHg (min) 245.3  ±  108.5 202.7  ±  186.2 0.25
AUC MAP <65mmHg 1440.9  ±  906.0 1430.0  ±  1924.6 <0.01
Time MAP <80% baseline (min) 264.8  ±  155.4 364.9  ±  229.8 0.09
AUC <80% baseline 1997.5  ±  1959.4 4454.8  ±  4794.9 0.93
MAC 0.88  ±  0.1 0.94  ±  0.1 0.05
Intraop Crystalloid (mL) 4016.9  ±  1028.2 4096.2  ±  1489.8 0.83
Total Crystalloid (mL) 4391.3  ±  917.5 4511.2  ±  1497.9 0.69
Total Colloid (mL) 447.4  ±  157.7 470.2  ±  148.2 0.59
PRBC, n (%) 1.0 0.1 0.0 0.0 0.29
Pressors, n (%) 9.0 0.5 21.0 0.4 1.00
Pressor doses 4.4  ±  5.2 4  ±  3.2 0.77
Medication Requirement
Baseline Narcotic Use (mg/day) 1.2  ±  0.5 3.0  ±  1.1 0.35
Pre-op Narcotic (mg) 35.1  ±  2.6 22.6  ±  1.7 <0.01
Intra-op Narcotic (mg) 49.5  ±  13.9 114.4  ±  8.8 <0.01
Post-op Narcotic (mg) 10.27  ±  4.1 9.9  ±  2.6 0.94
Total Narcotic (mg) 95.2  ±  146.9  ±  9.3 0.01
Baseline Benzodiazepine (mg/day) 13.2  ±  57.6 32.7  ±  143.1 0.43
Pre-op Benzodiazepine (mg) 3.4  ±  0.4 3.5  ±  0.2 0.74
Intra-op Benzodiazepine (mg) 4.2  ±  0.5 1.5  ±  0.3 <0.01
Post-op Benzodiazepine (mg) 0.1  ±  0.04 0.02  ±  0.03 0.48
Total Benzodiazepine use (mg) 7.6  ±  0.4 5.1  ±  0.2 0.01
a

Intraoperative MAP, SBP, and DBP, and minutes with MAP < 65mmhg were adjusted for preoperative values.

b

Preoperative, intraoperative, post-operative, and total narcotic and benzodiazepine requirements were adjusted for baseline use. Narcotic use is reported in IV morphine equivalents. Benzodiazepine use is reported in IV midazolam equivilents.